SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAIVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL

被引：60

作者：

Jacobson, I. ^{[1
]}

Dore, G. J. ^{[2
]}

Foster, G. R. ^{[3
]}

Fried, M. W. ^{[4
]}

Radu, M. ^{[5
]}

Rafalskiy, V. V.

Moroz, L. ^{[6
]}

Craxi, A. ^{[7
]}

Peeters, M. ^{[8
]}

Lenz, O. ^{[8
]}

Ouwerkerk-Mahadevan, S. ^{[9
]}

Kalmeijer, R. ^{[10
]}

Beumont-Mauviel, M. ^{[8
]}

机构：

[1] Weill Cornell Med Coll, New York, NY USA

[2] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia

[3] Queen Mary Univ London, Barts Hlth, London, England

[4] Univ N Carolina, Chapel Hill, NC USA

[5] Inst Boli Infect, Bucharest, Romania

[6] Vinnytsia Natl Med Univ, Vinnytsia, Ukraine

[7] Azienda Osped Univ Policlin Paolo Giaccone, Palermo, Italy

[8] Janssen Infect Dis BVBA, Beerse, Belgium

[9] Jansssen Res & Dev, Beerse, Belgium

[10] Janssen Global Serv LLC, Titusville, NJ USA

来源：

关键词：

D O I：

10.1016/S0168-8278(13)61424-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1425

引用

页码：S574 / S574

页数：1